Mani Mohindru
CIK: 0001664708
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (7 total)
- Jul 14, 2026CRDF
Cardiff Oncology, Inc.
Purchase(P)Direct34.4K shares at avg. $1.46$50K - Jun 18, 2026CRDF
Cardiff Oncology, Inc.
Purchase(P)Direct24.7K shares at avg. $1.21$30K - Jun 17, 2026CTMX
CytomX Therapeutics, Inc.
Award(A)DirectStock Option (Right to Buy)
59K shares- - Mar 31, 2026CRDF
Cardiff Oncology, Inc.
Award(A)DirectStock Options
600K shares- - Feb 17, 2026CRDF
Cardiff Oncology, Inc.
Award(A)DirectStock Options
200K shares- - Jun 26, 2025CRDF
Cardiff Oncology, Inc.
Award(A)DirectStock Options
40.6K shares- - Jun 11, 2025CTMX
CytomX Therapeutics, Inc.
Award(A)DirectStock Option (Right to Buy)
38K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 14, 2026 |  CRDF Cardiff Oncology, Inc. | Purchase(P) | 34,364 | $1.46 | $50,000 | Direct |
| Jun 18, 2026 | CRDF Cardiff Oncology, Inc. | Purchase(P) | 24,703 | $1.21 | $29,891 | Direct |
| Jun 17, 2026 |  CTMX CytomX Therapeutics, Inc. | Award(A) Stock Option (Right to Buy) | 59,000 | - | - | Direct |
| Mar 31, 2026 | CRDF Cardiff Oncology, Inc. | Award(A) Stock Options | 600,000 | - | - | Direct |
| Feb 17, 2026 | CRDF Cardiff Oncology, Inc. | Award(A) Stock Options | 200,000 | - | - | Direct |
| Jun 26, 2025 | CRDF Cardiff Oncology, Inc. | Award(A) Stock Options | 40,565 | - | - | Direct |
| Jun 11, 2025 | CTMX CytomX Therapeutics, Inc. | Award(A) Stock Option (Right to Buy) | 38,000 | - | - | Direct |
1-7 of 7 transactions
About Mohindru Mani
Mohindru Mani (SEC CIK 0001664708) files insider reports with the SEC as Chief Executive Officer of Cardiff Oncology, Inc. (CRDF) and Director of CytomX Therapeutics, Inc. (CTMX).
Signal8 holds 7 ownership filings by Mohindru Mani, all Form 4s, filed between Jun 13, 2025 and Jul 16, 2026. Those filings report 7 transactions, from Jun 11, 2025 to Jul 14, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Mohindru Mani's filings is in SAN DIEGO, CA.
Recent filings by Mohindru Mani
- Jul 14, 2026: Open-market purchase of CRDF shares (Form 4, code P).
- Jun 18, 2026: Open-market purchase of CRDF shares (Form 4, code P).
- Jun 17, 2026: Grant or award of CTMX derivative securities (Form 4, code A).
- Mar 31, 2026: Grant or award of CRDF derivative securities (Form 4, code A).
- Feb 17, 2026: Grant or award of CRDF derivative securities (Form 4, code A).
Other insiders filing for Cardiff Oncology, Inc. (CRDF)
- Alland Leila, Chief Medical Officer
- PACE GARY W, Director
- Armitage James O, Director
- White Lale, Director
- TANNENBAUM RENEE P, Director
- Markin Rodney S, Director